Scientific Advisory Committee
AVEO Oncology, an LG Chem company, and LG Chem Life Sciences formed its Scientific Advisory Committee (“Committee”) in Q1 2024. This esteemed group of experts in oncology research and clinical development were selected to advise and bring unique perspectives to AVEO and LG Chem’s clinical strategy and business development initiatives. This group of top oncology experts will help guide drug development initiatives from discovery through commercialization. Notably, the Committee represents key areas of interest, including gastrointestinal, genitourinary, ovarian, lung and head and neck cancers.
The Committee is comprised of several leading cancer experts, including:
Al B. Benson III, MD, FACP, FACCC, FASCO
Professor of Medicine
Associate Director from Cooperative Groups
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
D. Ross Camidge, MD, PhD
Professor of Medicine/Oncology
Joyce Zeff Chair in Lung Cancer
Director, Thoracic Oncology
Faculty, Developmental Therapeutics Program
University of Colorado Cancer Center, Aurora
Edward Chu, MD, MMS
Director, Montefiore Einstein Cancer Center
Albert Einstein College of Medicine
Ezra Cohen, MD, FRCPSC, FASCO
Chief Medical Officer of Oncology Tempus
University of California-San Diego
Kevin J. Cullen, MD
Professor of Oncology
University of Maryland Marlene and Stewart
Greenebaum Comprehensive Cancer Center
University of Maryland School of Medicine
Enrique Grande, MD, PhD, MSc
Director, Medical Oncology Program and
Clinical Research Lead
MD Anderson Cancer Center Madrid
Scott Kopetz, MD, PhD
Professor and Deputy Chair for Translational
Research, Department of Gastrointestinal
Medical Oncology
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
John L. Marshall, MD
Chief, Hematology and Oncology
Professor of Medicine and Oncology
Director, Otto J Ruesch Center for the Cure of Gastrointestinal Cancers Georgetown Lombardi Comprehensive Cancer Center
Tony S.K. Mok, BBS, FASCO
Chairman, Department of Clinical Oncology
LiShu Fan Professor of Clinical Oncology
The Chinese University of Hong Kong
Dan Petrylak, MD
Professor of Medicine, Director of Genitourinary Oncology,
Co Director Signal Transduction Program,
Yale University Cancer Center
Paul G. Richardson, MD
Director, Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Joseph Tabernero, MD, PhD
Head, Medical Oncology Department
Director, Vall d’Hebron Institute of Oncology
Professor of Medicine, UVic-UCC
Jan Vermorken, MD, PhD
Emeritus Professor of Oncology
Department of Medical Oncology
Antwerp University Hospital